Heart Failure With Reduced Ejection Fraction (HFrEF)
Cardiovascular·MeSH: Heart Failure
Prevalence
1800.0 / 100K
Incidence
300.0 / 100K/yr
3 drugs in development·1 company·0 clinical trials
Drug Pipeline by Phase
Phase 3(1)
| Drug | Company |
|---|---|
| CardiAMP® | BioCardia, Inc. (BCDA) |
Compare drugs
Frequently asked questions
How many drugs are in development for Heart Failure With Reduced Ejection Fraction (HFrEF)?
BioSniper tracks 3 drugs in development for Heart Failure With Reduced Ejection Fraction (HFrEF) across 1 company.
What is the prevalence of Heart Failure With Reduced Ejection Fraction (HFrEF)?
The estimated prevalence of Heart Failure With Reduced Ejection Fraction (HFrEF) is approximately 1800.0 per 100,000 population.
Deep-dive into Heart Failure With Reduced Ejection Fraction (HFrEF)
Full trial data, competitive analysis, and AI-powered pipeline tracking.
Start Free Analysis